Cargando…
Pseudoephedrine—Benefits and Risks
Pseudoephedrine (PSE) is a drug with a long history of medical use; it is helpful in treating symptoms of the common cold and flu, sinusitis, asthma, and bronchitis. Due to its central nervous system (CNS) stimulant properties and structural similarity to amphetamine, it is also used for non-medical...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152226/ https://www.ncbi.nlm.nih.gov/pubmed/34067981 http://dx.doi.org/10.3390/ijms22105146 |
_version_ | 1783698558958960640 |
---|---|
author | Głowacka, Krystyna Wiela-Hojeńska, Anna |
author_facet | Głowacka, Krystyna Wiela-Hojeńska, Anna |
author_sort | Głowacka, Krystyna |
collection | PubMed |
description | Pseudoephedrine (PSE) is a drug with a long history of medical use; it is helpful in treating symptoms of the common cold and flu, sinusitis, asthma, and bronchitis. Due to its central nervous system (CNS) stimulant properties and structural similarity to amphetamine, it is also used for non-medical purposes. The substance is taken as an appetite reducer, an agent which eliminates drowsiness and fatigue, to improve concentration and as a doping agent. Due to its easier availability, it is sometimes used as a substitute for amphetamine or methamphetamine. Pseudoephedrine is also a substrate (precursor) used in the production of these drugs. Time will tell whether legal restrictions on the sale of this drug will reduce the scale of the problem associated with its misuse. |
format | Online Article Text |
id | pubmed-8152226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81522262021-05-27 Pseudoephedrine—Benefits and Risks Głowacka, Krystyna Wiela-Hojeńska, Anna Int J Mol Sci Review Pseudoephedrine (PSE) is a drug with a long history of medical use; it is helpful in treating symptoms of the common cold and flu, sinusitis, asthma, and bronchitis. Due to its central nervous system (CNS) stimulant properties and structural similarity to amphetamine, it is also used for non-medical purposes. The substance is taken as an appetite reducer, an agent which eliminates drowsiness and fatigue, to improve concentration and as a doping agent. Due to its easier availability, it is sometimes used as a substitute for amphetamine or methamphetamine. Pseudoephedrine is also a substrate (precursor) used in the production of these drugs. Time will tell whether legal restrictions on the sale of this drug will reduce the scale of the problem associated with its misuse. MDPI 2021-05-13 /pmc/articles/PMC8152226/ /pubmed/34067981 http://dx.doi.org/10.3390/ijms22105146 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Głowacka, Krystyna Wiela-Hojeńska, Anna Pseudoephedrine—Benefits and Risks |
title | Pseudoephedrine—Benefits and Risks |
title_full | Pseudoephedrine—Benefits and Risks |
title_fullStr | Pseudoephedrine—Benefits and Risks |
title_full_unstemmed | Pseudoephedrine—Benefits and Risks |
title_short | Pseudoephedrine—Benefits and Risks |
title_sort | pseudoephedrine—benefits and risks |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152226/ https://www.ncbi.nlm.nih.gov/pubmed/34067981 http://dx.doi.org/10.3390/ijms22105146 |
work_keys_str_mv | AT głowackakrystyna pseudoephedrinebenefitsandrisks AT wielahojenskaanna pseudoephedrinebenefitsandrisks |